Invention Grant
![Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors](/docs/US/2018-06-05/US09988387B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
-
Application No.: US14918879Application Date: 2015-10-21
-
Publication No.: US09988387B2Publication Date: 2018-06-05
- Inventor: Jincong Zhuo , Chunhong He , Wenqing Yao
- Applicant: Incyte Holdings Corporation , Incyte Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Lathrop Gage LLP
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D403/04 ; A61K31/53 ; A61P35/00
![Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors](/abs-image/US/2018/06/05/US09988387B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to imidazo[1,2-b][1,2,4]triazines that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer.
Public/Granted literature
- US20160137650A1 IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS Public/Granted day:2016-05-19
Information query
